Ziopharm Oncology (ZIOP) Reports In-Line Q2 EPS
Tweet
Share
E-mail
Get Alerts ZIOP Hot Sheet
Price: $0.87 --0%
Financial Fact:
Total operating expenses: 12.51M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Total operating expenses: 12.51M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Ziopharm Oncology (NASDAQ: ZIOP) reported Q2 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $1.66 million.
For earnings history and earnings-related data on Ziopharm Oncology (ZIOP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Keefe, Bruyette & Woods Starts Columbia Financial Inc (CLBK) at Outperform
- Movano (MOVE) Misses Q2 EPS by 195c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
